Company / Net Debt per Share
Caris Life Sciences, Inc. Net Debt per Share History
FY2025-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
-$11.45
FY2025
5-year range
-$11.45 / -$11.45
FY2025-FY2025
Trend
-
vs FY2024
Sector context
#95 of 98
Health Care
What the data says
Among 98 Health Care companies, Caris Life Sciences, Inc. is in the top 3% for net debt per share.
Based on SEC 10-K filings.
-11.45 in FY2025.
Health Care sector context is included.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 3% in Health CareTop 3% of 98This company -$11.45 Sector average $7.89
▼
-245.1% below sector average
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$11.45 | - |
| FY2024 | - | - |
| FY2023 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026